Concurrently, we evaluated the efficacy of OTX008, a pre-existing Gal-1 inhibitor tested for treating advanced solid tumors in 2012 (ClinicalTrials.gov: NCT01724320), against MPNST cells. The gene discussed is LGALS1; the disease is malignant peripheral nerve sheath tumor.